Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
payers
Description:
Individuals or organizations responsible for paying for healthcare services or products, including insurers, public programs, and patients.
Primary topic:
Pharmaceutical Economics and Policy (27%)
Related topics:
Pharmaceutical Economics and Policy (27%),
Health Systems, Economic Evaluations, Quality of Life (15%),
Healthcare Policy and Management (14%)
OpenAlex ID:
keywords/payers
The Value Of Health Care Information Exchange And Interoperability
2005
·
Jan Walker
, Eric Pan
, et al.
·
Health Affairs
·
912
The State of Innovation in Drug Development
2008
·
I Kola
·
Clinical Pharmacology & Therapeutics
·
313
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
2010
·
Jakub Adamski
, Brian Godman
, et al.
·
BMC Health Services Research
·
294
PDF
Health Spending Projections Through 2015: Changes On The Horizon
2006
·
Christine Borger
, Sheila Smith
, et al.
·
Health Affairs
·
280
Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity
2020
·
Hassane Alami
, Pascale Lehoux
, et al.
·
Journal of Medical Internet Research
·
213
Opportunities and challenges in using real-world data for health care
2020
·
Vivek A. Rudrapatna
, Atul J. Butte
·
Journal of Clinical Investigation
·
208
PDF
Patient reported outcomes: looking beyond the label claim
2010
·
Lynda C Doward
, Ari Gnanasakthy
, et al.
·
Health and Quality of Life Outcomes
·
174
PDF
Factors Affecting the Adoption of Telemedicine—A Multiple Adopter Perspective
2004
·
Nir Menachemi
, Darrell E. Burke
, et al.
·
Journal of Medical Systems
·
164
The development of group purchasing: an empirical study in the healthcare sector
2003
·
Jean Nollet
, Martin Beaulieu
·
Journal of Purchasing and Supply Management
·
161
Measuring the Value of Prescription Drugs
2015
·
Peter J. Neumann
, Joshua T. Cohen
·
New England Journal of Medicine
·
159
More quality measures versus measuring what matters: a call for balance and parsimony
2012
·
Gregg S Meyer
, Eugene C Nelson
, et al.
·
BMJ Quality & Safety
·
159
PDF
Transforming Evidence Generation to Support Health and Health Care Decisions
2016
·
Robert M. Califf
, Melissa A. Robb
, et al.
·
New England Journal of Medicine
·
152
PDF
Gene therapies development: slow progress and promising prospect
2017
·
Eve Hanna
, Cécile Rémuzat
, et al.
·
Journal of Market Access & Health Policy
·
151
PDF
Patient-Focused Drug Development: A New Direction for Collaboration
2014
·
Eleanor M. Perfetto
, Laurie Burke
, et al.
·
Medical Care
·
151
Market Driven Health Care: Who Wins, Who Loses in the Transformation of America's Largest Service Industry
1996
·
Regina E. Herzlinger
·
DigitalGeorgetown (Georgetown University Library)
·
140
Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments
2018
·
Rachel Salzman
, Francesca Cook
, et al.
·
Molecular Therapy
·
137
PDF
Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020
2022
·
William W. Thompson
, Hasan Symum
, et al.
·
MMWR Morbidity and Mortality Weekly Report
·
134
PDF
A reimbursement framework for artificial intelligence in healthcare
2022
·
Michael D. Abràmoff
, Cybil Roehrenbeck
, et al.
·
npj Digital Medicine
·
134
PDF
Early Patient-Centered Outcomes Research Experience With the Use of Telehealth to Address Disparities: Scoping Review
2021
·
James E Bailey
, Cathy Gurgol
, et al.
·
Journal of Medical Internet Research
·
132
A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines
2013
·
Jon Sussex
, Pierrick Rollet
, et al.
·
Value in Health
·
129
Risk-Sharing Arrangements That Link Payment For Drugs To Health Outcomes Are Proving Hard To Implement
2011
·
Peter J. Neumann
, James D. Chambers
, et al.
·
Health Affairs
·
125
Gene therapy: evidence, value and affordability in the US health care system
2017
·
Grace Hampson
, Adrian Towse
, et al.
·
Journal of Comparative Effectiveness Research
·
124
Quantifying factors for the success of stratified medicine
2011
·
Mark R. Trusheim
, Breon Burgess
, et al.
·
Nature Reviews Drug Discovery
·
116
Improving Social Needs Intervention Research: Key Questions for Advancing the Field
2019
·
Caroline M. Fichtenberg
, Dawn E. Alley
, et al.
·
American Journal of Preventive Medicine
·
108
PDF
The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat
2018
·
Alison D. Marshall
, Jean-Michel Pawlotsky
, et al.
·
Journal of Hepatology
·
106
Show more works
View as search
Works count:
1,860
Citation count:
15,870
Year
Topic
Type